Episodes

  • Advances in Retinal Therapy: Emerging Strategies for DME and wAMD

    Advances in Retinal Therapy: Emerging Strategies for DME and wAMD
    Jul 28 2025
    Drs. Armstrong and Patel discuss current and emerging therapies for diabetes-related macular edema and wet age-related macular degeneration including anti-VEGF agents, the need for durability and reduced treatment burden, alternative delivery strategies, novel molecules, and gene-therapy.
    Show more Show less
    12 mins
  • Richard Ostfeld on Tick-Borne Threats in Changing Ecosystems

    Richard Ostfeld on Tick-Borne Threats in Changing Ecosystems
    Jul 25 2025
    Dr. Richard S. Ostfeld discusses how human disruption of natural ecosystems, such as forest fragmentation and predator loss, has increased the risk of tick-borne diseases like Lyme and Powassan virus. He explains how climate change extends tick seasons and how common hosts like mice thrive in altered environments, boosting tick populations. Despite promising tick-control interventions, personal prevention remains key, as broad environmental strategies have yet to show consistent reductions in human disease.
    Show more Show less
    24 mins
  • AI and Telehealth in Diabetic Retinopathy: From Screening to Specialist Care

    AI and Telehealth in Diabetic Retinopathy: From Screening to Specialist Care
    Jul 22 2025
    Drs. Patel and Armstrong discuss the implementation and evaluation of AI-powered diabetic retinopathy and diabetes-related macular edema screening and telemedicine, including ways to handle an influx of referrals, questions about reimbursement, staffing, and liability.
    Show more Show less
    9 mins
  • GLP-1s and the Retinal Patient: What Every Eye Care Professional Should Know

    GLP-1s and the Retinal Patient: What Every Eye Care Professional Should Know
    Jul 21 2025
    Drs. Modi and Dedania discuss GLP-1 receptor agonists and the retinal patient, including how GLP-1 receptor agonists work, benefits and risks in patients with retinal disease, and data from retrospective studies.
    Show more Show less
    11 mins
  • Floaters: Imaging Tools, Decision-Making, Including Surgery and Patient Counseling

    Floaters: Imaging Tools, Decision-Making, Including Surgery and Patient Counseling
    Jul 18 2025
    Drs. Dedania and Modi discuss vitreous opacities, or floaters, including imaging, evaluating, and when and whether to pursue surgery. They discuss conditional circumstances that may influence whether to pursue surgery or not, as well as patient counseling.
    Show more Show less
    10 mins
  • Geographic Atrophy: Navigating the Latest Advances in Care

    Geographic Atrophy: Navigating the Latest Advances in Care
    Jul 17 2025
    Drs. Modi and Dedania discuss imaging, biomarkers, and diagnosis in geographic atrophy, as well as current therapies and those in late stage clinical trials.
    Show more Show less
    10 mins
  • “What does full FDA approval of Moderna’s COVID vaccine mean for high-risk kids under 12?”

    “What does full FDA approval of Moderna’s COVID vaccine mean for high-risk kids under 12?”
    Jul 16 2025
    This podcast highlights three updates: Moderna’s Spikevax COVID-19 vaccine is now fully FDA-approved for high-risk children 6 months to 11 years, though rare myocarditis remains a concern. A large study found first-trimester TMP-SMX antibiotics increase congenital malformation risks compared to β-lactams, reinforcing β-lactams as safer. Finally, a trial showed no cardiovascular benefit from taking blood pressure medication at bedtime versus morning dosing.
    Show more Show less
    5 mins
  • Maintenance Therapy Strategies in Small Cell Lung Cancer

    Maintenance Therapy Strategies in Small Cell Lung Cancer
    Jul 14 2025
    Drs. Sabari and Socinski discuss maintenance therapy strategies in small cell lung cancer, including immunotherapy, chemotherapy, targeted agents, and radiation.
    Show more Show less
    13 mins